van SantenHM, TytgatGAM, van de WeteringMD, van Eck-SmitBLF, HopmanSMJ, van der SteegAF, Nieveen van DijkumEJM, van TrotsenburgASP. 2012. Differentiated thyroid carcinoma after (131)I-MIBG treatment for neuroblastoma during childhood: description of the first 2 cases. Thyroid, 22:643–646.
2.
FioreE, VittiP. 2012. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. J Clin Endocrinol Metab, 97:1134–1145.
3.
BergerC, Trombert-PaviotB, CasagrandaL, MialouV, FrappazD, PlantazD, Collardeau-FrachonS, FreyconF. 2011. Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987–2004) from the childhood cancer registry of the Rhône-Alpes region (ARCERRA) in France. Pediatr Hematol Oncol, 28:364–379.
4.
KleinermanRA, TuckerMA, TaroneRE, AbramsonDH, SeddonJM, StovallM, LiFP, FraumeniJFJr. 2005. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol, 23:2272–2279.
5.
BhattiP, VeigaLH, RonckersCM, SigurdsonAJ, StovallM, SmithSA, WeathersR, LeisenringW, MertensAC, HammondS, FriedmanDL, NegliaJP, MeadowsAT, DonaldsonSS, SklarCA, RobisonLL, InskipPD. 2010. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res, 174:741–752.
6.
de VathaireF, HardimanC, ShamsaldinA, CampbellS, GrimaudE, HawkinsM, RaquinM, OberlinO, DialloI, ZuckerJM, PanisX, LagrangeJL, Daly-SchveitzerN, LemerleJ, ChavaudraJ, SchlumbergerM, BonaïtiC. 1999. Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med, 159:2713–2719.
